Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04636892 · ClinicalTrials.gov registry record · NA

Evaluating Infrasonic Hemodynography

A NA study of Cardiovascular Diseases and Coronary Artery Disease, sponsored by Scripps Health.

Recruiting
Registry status
NA
Development phase
25
Enrollment target
1
Study location

NCT04636892 is a NA study of Cardiovascular Diseases and Coronary Artery Disease that is actively recruiting participants, run by Scripps Health. The registered enrollment target is 25 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04636892, a NA study of Cardiovascular Diseases and Coronary Artery Disease, is actively recruiting participants, sponsored by Scripps Health.

RECRUITING
Registry status
NA
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

This comparative diagnostic accuracy study will determine the accuracy of a noninvasive wearable infrasonic sensor to detect the mechanical, electrical, and hemodynamic function of the cardiovascular system.

Interventions

  • OTHER MindMics earbud

Study Locations (1)

California

  • Scripps Health - La Jolla

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2021-01-04
Est. Completion 2025-12-01
Phase NA

Sponsor

Scripps Health

30 total trials

What the Registry Record Tells You About NCT04636892

The ClinicalTrials.gov registry entry for NCT04636892 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The listed sponsor is Scripps Health, which has 30 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which MindMics earbud is the first listed.

NCT04636892 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04636892 about?

NCT04636892 is a clinical study titled "Evaluating Infrasonic Hemodynography". This comparative diagnostic accuracy study will determine the accuracy of a noninvasive wearable infrasonic sensor to detect the mechanical, electrical, and hemodynamic function of the cardiovascular system.

What is the current status of trial NCT04636892?

This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2021-01-04. Estimated completion is 2025-12-01.

What conditions does trial NCT04636892 study?

This clinical trial studies the following conditions: Cardiovascular Diseases, Coronary Artery Disease, Pulmonary Hypertension, Aortic Stenosis, Mitral Regurgitation.

What interventions are being tested in trial NCT04636892?

The interventions under investigation include: MindMics earbud (OTHER).

Who is sponsoring clinical trial NCT04636892?

This trial is sponsored by Scripps Health, which has 30 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04636892 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.